As the threat of antibiotic resistance grows, a Swansea University academic has led the development of a novel technology ...

“With the addition of Tobramycin, Ritedose now provides the largest nebulized drug portfolio in the country,” said Ritedose CEO Jody Chastain in the release. “Our recent investments in expanded ...

Carbapenem-resistant Enterobacterales species and multidrug-resistant Pseudomonas aeruginosa are global health threats. Cefepime–taniborbactam is an investigational β-lactam and β-lactamase inhibitor ...

Pseudomonas aeruginosa -- an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions -- evolved rapidly and then spread ...

BiomX Inc (PHGE) progresses in clinical trials for BX004 and BX011, despite facing financial constraints and a temporary FDA ...